
Ventyx Biosciences, Inc.
USD14.00
+0.00 (+0.00%)
CEO
Sheila K. Gujrathi
IPO Date
2021-10-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.00
Prev. Close
$14.00
Day Low
$14.00
Day High
$14.00
52W Low
$0.78
52W High
$25.00
Market Cap
$1.00B
Volume
5.40M
| 8 Jan 2026 |
| Canaccord Genuity |
| Buy |
| Hold |
| downgrade |
| 8 Jan 2026 | UBS | Buy | Neutral | downgrade |
| 8 Jan 2026 | LifeSci Capital | Outperform | Market Perform | downgrade |
| 7 Nov 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 7 Nov 2025 | Canaccord Genuity | Buy | Buy | maintain |
| 5 Nov 2025 | HC Wainwright & Co. | Neutral | Buy | upgrade |
| 27 Oct 2025 | Oppenheimer | Outperform | Outperform | maintain |